Most common adverse events at all doses: Nausea (3355%, dose-related) Vomiting (1335%) Decreased appetite (1528%) Constipation or diarrhea (1020%) Injection-site reaction (510%) Dose-related dysesthesia signal: The TRIUMPH-4 trial identified a dose-related dysesthesia (nerve-tingling, paresthesia) signal: This is the most-flagged trial-level safety signal for retatrutide and the reason community doses cluster at 2-4 mg/week well below where the dysesthesia signal becomes prominent
Additionally, try to incorporate strength training exercises at least twice a week to build muscle mass and work all of your major muscle groups
EHH, endogenous hyperinsulinemic hypoglycemia
For instance, regulatory uncertainty around health claims for glutathione derivatives can hinder marketing strategies, creating barriers for new entrants and limiting rapid market expansion
Advances in anti-obesity pharmacotherapy: current treatments, emerging therapies, and challenges
The However, youll most likely need more exercise to help maintain weight loss after stopping semaglutide